Parametric Response Map as an Imaging Biomarker to Distinguish Progression From Pseudoprogression in High-Grade Glioma

Journal of Clinical Oncology - United States
doi 10.1200/jco.2009.25.3971
Full Text
Abstract

Available in full text

Date
Authors
Publisher

American Society of Clinical Oncology (ASCO)

Related search

Diffusion Kurtosis MRI as a Predictive Biomarker of Response to Neoadjuvant Chemotherapy in High Grade Serous Ovarian Cancer

Scientific Reports
Multidisciplinary
2019English

Parametric Response Map Image Analysis for Response to Cancer Treatment

Science-Business eXchange
2009English

Circulating Biomarkers for High-Grade Glioma

Biomarkers in Medicine
BiochemistryDrug DiscoveryClinical Biochemistry
2019English

Predicting Disease Progression in High-Grade Glioma With Neuropsychological Parameters: The Value of Personalized Longitudinal Assessment

Journal of Neuro-Oncology
Cancer ResearchOncologyNeurology
2019English

High-Grade Glioma Management and Response Assessment—recent Advances and Current Challenges

Current Oncology
Oncology
2016English

Mp21-02 Novel Quantitative Imaging Algorithms Distinguish Localized and Metastatic High-Grade Primary Prostate Cancers

Journal of Urology
Urology
2016English

Post-Operative Perfusion and Diffusion MR Imaging and Tumor Progression in High-Grade Gliomas

PLoS ONE
Multidisciplinary
2019English

Echo-Planar MR Spectroscopic Imaging Pre and Post Radiation Therapy in Patients With High Grade Glioma

International Journal of Radiation Oncology Biology Physics
OncologyRadiologyCancer ResearchRadiationNuclear MedicineImaging
2015English

MAPT (Tau) Expression Is a Biomarker for an Increased Rate of Survival for Low‑grade Glioma

Oncology Reports
MedicineCancer ResearchOncology
2018English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy